Synlett, Table of Contents Synlett 2019; 30(19): 2173-2180DOI: 10.1055/s-0039-1690226 letter © Georg Thieme Verlag Stuttgart · New Yorkα-d-Galacturonic Acid as Natural Ligand for Selective Copper-Catalyzed N-Arylation of N-Containing Heterocycles Chunling Yuan ∗ , Yingdai Zhao , Li ZhengRecommend Article Abstract Buy Article All articles of this category Abstract The first application of α-d-galacturonic acid hydrate (GalA) is reported here, as a potential O-donor ligand. The C–N couplings of N-heterocycles with aryl halides or arylboronic acids could be readily conducted and exhibited good functional group tolerance with characters of selectivity. These N-arylazoles allow rapid access to several pharmaceutical intermediates and can be easily transformed into a variety of other interesting scaffolds as well. Key words Key wordsα-d-galacturonic acid hydrate - C–N couplings - N-arylation - Cu catalyst - ligand Full Text References References and Notes 1 Cozzi P, Arganico G, Fusar D, Grossoni M, Menichincheri M, Pinciroli V, Tonani R, Vaghi F, Salvati P. J. Med. Chem. 1993; 36: 2964 2 Penning TD, Talley JJ, Bertenshaw SR, Carter JS, Collins PW, Docter S, Graneto MJ, Lee LF, Malecha JW, Miyashiro JM. J. Med. Chem. 1997; 40: 1347 3 Kirchner T, Aparicio B, Argentieri DC, Lau CY, Ritchie DM. Prostag. Leukotr. Ess. 1997; 56: 417 4 Wong PC, Crain EJ, Xin B, Wexler RR, Lam PY. S, Pinto DJ, Luettgen JM, Knabb RM. J. Thromb. Haemost. 2008; 6: 820 5 Ueda S, Su MJ, Buchwald SL. J. Am. Chem. Soc. 2012; 134: 700 6 Juruena MF, Ponde de Sena E, Reis de Oliveira I. J. Cent. Nerv. Syst. Dis. 2011; 3: 75 7 Beletskaya IP, Cheprakov AV. Coord. Chem. Rev. 2004; 248: 2337 8 Monnier F, Taillefer M. Angew. Chem. Int. Ed. 2009; 48: 6954 9 Ullmann F. Ber. Dtsch. Chem. Ges. 1903; 36: 2382 10a Evano G, Blanchard N, Toumi M. Chem. Rev. 2008; 108: 3054 10b Bhunia S, Pawar GG, Kumar SV, Jiang Y, Ma D. Angew. Chem. Int. Ed. 2017; 56: 16136 10c Ma D, Cai Q. Acc. Chem. Res. 2008; 41: 1450 11 Lv X, Bao W. J. Org. Chem. 2007; 72: 3863 12 Altman RA, Buchwald SL. Org. Lett. 2006; 8: 2779 13 Altman RA, Koval ED, Buchwald SL. J. Org. Chem. 2007; 72: 6190 14 Antilla JC, Klapars A, Buchwald SL. J. Am. Chem. Soc. 2002; 124: 11684 15 Antilla JC, Baskin JM, Barder TE, Buchwald SL. J. Org. Chem. 2004; 69: 5578 16 Zhang H, Cai Q, Ma D. J. Org. Chem. 2005; 70: 5164 17 Ma D, Cai Q. Acc. Chem. Res. 2008; 41: 1450 18 Cristau HJ, Cellier PP, Spindler JF, Taillefer M. Eur. J. Org. Chem. 2004; 4: 695 19 Guo X, Rao H, Fu H, Jiang Y, Zhao Y. Adv. Synth. Catal. 2006; 348: 2197 20 Mao J, Guo J, Song H, Ji S. Tetrahedron 2008; 64: 1383 21 Liu L, Frohn M, Xi N, Dominguez C, Hungate R, Reider PJ. J. Org. Chem. 2005; 70: 10135 22 Wang H, Li Y, Sun F, Feng Y, Jin K, Wang X. J. Org. Chem. 2008; 73: 8639 23 Feng YS, Man QS, Pan P, Pan ZQ, Xu HJ. Tetrahedron Lett. 2009; 50: 2585 24 Thakur KG, Sekar G. Chem. Commun. 2011; 47: 6692 25 Wei JJ, Song WB, Zhu YF, Wei BL, Xuan LJ. Tetrahedron 2018; 74: 19 26 Tang HR, Belton PS, Davies SC, Hughes DL. Carbohyd. Res. 2001; 330: 391 27 Ippolito M, Girasolo MA, Saiano F, Attanzio A, Rotondo A, Rubino S, Mondello L, Capobianco ML, Sabatino P, Tesoriere L, Casella G. J. Inorg. Biochem. 2018; 188: 102 28 Bermúdez-Oria A, Rodríguez-Gutiérrez G, Alaiz M, Vioque J, Girón-Calle J, Fernández-Bolaños J. Food Funct. 2019; 10: 4844 29 Akeshi K. New Food Ind. 2005; 47: 43 30 Surry DS, Buchwald SL. Chem. Sci. 2010; 1: 13 31 Susan L, Buonerba F, Goracci L, Velilla I, Ruzziconi R, Schindler BD, Seo SM, Kaatz GW, Cruciani G. J. Med. Chem. 2016; 59: 867 32 Rodriguez AD, Ramirez C, Rodriguez II, Gonzalez E. Org. Lett. 1999; 1: 527 33 Allen SE, Walvoord RR, Padilla-Salinas R, Kozlowski MC. Chem. Rev. 2013; 113: 6234 34 Tye JW, Weng Z, Johns AM, Incarvito CD, Hartwig JF. J. Am. Chem. Soc. 2008; 130: 9971 35 Ribas X, Güell I. Pure Appl. Chem. 2014; 86: 345 36 Taillefer M, Xia N, Ouali A. Angew. Chem. Int. Ed. 2007; 46: 934 37 Ali MA, Saha P, Punniyamurthy T. Synthesis 2010; 908 38 Jammi S, Sakthivel S, Rout L, Mukherjee T, Mandal S, Mitra R, Saha P, Punniyamurthy T. J. Org. Chem. 2009; 74: 1971 39 Antilla JC, Baskin JM, Barder TE, Buchwald SL. J. Org. Chem. 2004; 69: 5578 40 Sun C, Cheng C, Sun G, Wan J. Synlett 2009; 2663 41 Che C, Li S, Yang S, Xin S, Yu Z, Shao T, Tao C, Lin S, Yang Z. Beilstein J. Org. Chem. 2012; 8: 841 42 Yang K, Qui Y, Li Z, Wang Z, Jiang S. J. Org. Chem. 2011; 76: 3151 43 dos Santos MS, Gomes AO, Bernardino AM. R, de Souza MC, Khan MA, de Brito MA, Castro HC, Abreu PA, Rodrigues CR, de Léo RM. M, Leon LL, Canto-Cavalheiro MM. J. Brazil. Chem Soc. 2011; 22: 352 44 Miah AH, Copley AH. B, O’Flynn D, Percy JM, Procopiou PA. Org. Biomol. Chem. 2014; 12: 1779 45 Jia X, Yang D, Wang W, Luo F, Cheng J. J. Org. Chem. 2009; 74: 9470 46 Li L, Liu J, Shi MA. Org. Lett. 2018; 20: 7076 47 Young MB, Barrow JC, Glass KL, Lundell GF, Newton CL, Pellicore JM, Rittle KE, Selnick HG, Stauffer KJ, Vacca JP, Williams PD, Bohn D, Clayton FC, Cook JJ, Krueger JA, Kuo LC, Lewis SD, Lucas BJ, McMasters DR, Miller-Stein C, Pietrak BL, Wallace AA, White RB, Wong B, Yan Y, Nantermet PG. J. Med. Chem. 2004; 47: 2995 48 Velezheva VS, Kornienko AG, Topilin SV, Turashev AD, Peregudov AS, Brennan PJ. J. Heterocycl. Chem. 2006; 43: 873 49 Grinev AN, Shvedov VI, Panisheva EK. Chem. Heterocycl. Compd. 1966; 2: 287 50 Fukata G, ltohtt T, Tashiro M. Heterocycles. 1982; 19: 1487 51 Inés B, SanMartin R, Churruca F, Domínguez E, Urtiaga MK, Arriortua MI. Organometallics. 2008; 27: 2833 52 Xing R, Li Y, Liu Q, Meng Q, Li J, Shen X, Liu Z, Zhou B, Yao X, Liu Z. Eur. J. Org. Chem. 2010; 6627 53 Saha P, Ramana T, Purkait N, Ali MA, Paul R, Punniyamurthy T. J. Org. Chem. 2009; 74: 8719 54 Xu L, Zhu D, Wu F, Wang R, Wan B. Tetrahedron 2005; 61: 6553 55 Teo Y, Chua G. Chem. Eur. J. 2009; 15: 3072 56 Rampazzi V, Massard A, Richard P, Picquet M, Gendre PL, Hierso J. ChemCatChem 2012; 4: 1828 57 Tao S, Ji E, Shi L, Liu N, Xu L, Dai B. Synthesis 2017; 49: 5120 58 Tye JW, Weng Z, Johns AM, Incarvito CD, Hartwig JF. J. Am. Chem. Soc. 2008; 130: 9971 59 General Procedure All of the starting materials, reagents, and solvents are commercially available and used without further purification. Melting points were determined with a X-4 apparatus and were uncorrected. The nuclear magnetic resonance (NMR) spectra were recorded on a Bruker 400 MHz spectrometer in CDCl3 or DMSO-d 6 using tetramethylsilane (TMS) as an internal standard. Electrospray ionization mass spectrometry (MS (ESI)) analyses were recorded in an Agilent 1100 Series MSD Trap SL (Santa Clara, CA, USA). The reactions were monitored by thin-layer chromatography (TLC: HG/T2354-92, GF254), and compounds were visualized on TLC with UV light. 60 General Procedure for Catalytic Experiments To a 10 mL vial was charged with aryl halide (0.8 mmol), N-containing heterocycle (1.0 mmol), CuBr (0.04 mmol), GalA (0.08 mmol), K2CO3 (2.4 mmol), and 50% aq DMSO. The flask was evacuated and backfilled with argon three times, and the reaction mixture was stirred at appropriate temperature under oil bath for the indicated time. After the complete consumption of aryl halide monitored by TLC, the mixture was then cooled to ambient temperature (if the product was acidic, the mixture was acidified), diluted with ethyl acetate (5 mL), filtered via a Celite pad, and washed with ethyl acetate (10–20 mL). The organic layer was separated by the separating funnel, which was washed successively with water (2 × 10 mL) and brine (2 × 10 mL). The organic layer was dried over anhydrous MgSO4 and concentrated by reduced pressure in a rotary evaporator, which was then purified by column chromatography on silica gel to provide the desired products. 1-Phenyl-1H-pyrazole (3a)36 Yield: 0.109 g (95%), colorless oil. 1H NMR (400 MHz, CDCl3): δ = 7.93–7.92 (d, J = 2.4 Hz, 1 H), 7.73–7.68 (m, 3 H), 7.47–7.43 (m, 2 H), 7.30–7.25 (m, 1 H), 6.46 (t, J = 2.3 Hz, 1 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 141.0, 129.3, 126.7, 126.4, 119.1, 107.5 ppm. MS (ESI+): m/z = 145.04 [M + H]+. 1-Phenyl-1H-imidazole (3b)37 Yield: 0.113 g (98%), colorless oil. 1H NMR (400 MHz, DMSO-d 6): δ = 8.28 (s, 1 H), 7.77 (s, 1 H), 7.67–7.64 (m, 2 H), 7.54–7.50 (m, 2 H), 7.37 (t, J = 7.4 Hz, 1 H), 7.14 (s, 1 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 137.3, 135.5, 130.3, 129.8, 127.4, 121.4, 118.2 ppm. MS (ESI+): m/z = 145.04 [M + H]+. 2-Methyl-1-(4-nitrophenyl)-1H-imidazole (3c)38 Yield: 0.136 g (84%), light yellow solid; mp 128–130 °C (lit. mp 140–142 °C). 1H NMR (400 MHz, DMSO-d 6): δ = 8.38 (d, J = 9.0 Hz, 2 H), 7.78 (d, J = 9.0 Hz, 2 H), 7.45 (d, J = 1.3 Hz, 2 H), 7.0 (d, J = 1.2 Hz, 1 H), 2.38 (s, 3 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 146.8, 144.4, 143.1, 128.7, 125.7, 125.1, 120.1, 14.1 ppm. MS (ESI+): m/z = 204.05 [M + H]+. 4-Methyl-1-phenyl-1H-imidazole (3d)39 and 5-Methyl-1-phenyl-1H-imidazole (3e)40 Yield: 0.123 g (97%), yellow oil. 1H NMR (400 MHz, CDCl3, 3d/3e = 7.6:1): δ = 7.76 (d, J = 1.3 Hz, 1 H), 7.57 (br, 0.13 H), 7.50–7.49 (m, 0.2 H), 7.48–7.43 (m, 2 H), 7.37–7.33 (m, 3 H), 7.32–7.28 (m, 0.5 H), 7.01 (t, J = 1.0 Hz, 1 H), 6.91 (br, 0.13 H), 2.31 (d, J = 1.0 Hz, 3 H), 2.18 (d, J = 1.0 Hz, 0.42 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 139.5, 137.5, 134.6, 129.8, 129.5, 128.3, 127.1, 125.6, 121.1, 114.6, 13.7 ppm. MS (ESI+): m/z = 159.09 [M + H]+. 3-(1H-Pyrazol-1-yl)benzaldehyde (3f)41 Yield: 0.096 g (70%), off-white solid; mp 28–30 °C. 1H NMR (400 MHz, CDCl3): δ = 10.08 (s, 1 H), 8.19 (t, J = 1.8 Hz, 1 H), 8.05–8.02 (m, 2 H), 7.81–7.76 (m, 2 H), 7.64 (t, J = 7.9 Hz, 1 H), 6.52 (t, J = 2.1 Hz, 1 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 191.4, 141.6, 136.5, 135.8, 130.2, 127.6, 125.9, 124.6, 119.0, 108.3 ppm. MS (ESI+): m/z = 173.08 [M + H]+. 1-(4-(1H-Pyrazol-1-yl)phenyl)ethan-1-one (3g)42 Yield: 0.119 g (80%), white solid; mp 101–104 °C (lit. mp 108 °C). 1H NMR (400 MHz, CDCl3): δ = 8.08–8.05 (m, 2 H), 8.02 (d, J = 2.5 Hz, 1 H), 7.83–7.81 (m, 2 H), 7.78 (d, J = 1.5 Hz, 1 H), 6.52 (t, J = 2.0 Hz, 1 H), 2.63 (s, 3 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 196.7, 143.2, 142.0, 134.7, 129.9, 126.8, 118.3, 108.5, 26.5 ppm. MS (ESI+): m/z = 187.09 [M + H]+. 1-(4-Nitrophenyl)-1H-pyrazole-4-carbaldehyde (3h)43 Yield: 0.162 g (93%), yellow solid; mp 158–160 °C (lit. mp 84 °C). 1H NMR (400 MHz, CDCl3): δ = 10.02 (s, 1 H), 8.55 (s, 1 H), 8.41–8.38 (m, 2 H), 8.23 (s, 1 H), 7.97–7.94 (m, 2 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 183.7, 146.6, 143.3, 142.6, 130.3, 126.6, 125.5, 119.7 ppm. MS (ESI+): m/z = 218.34 [M + H]+. 3-(1H-Pyrazol-1-yl)pyridin-2-amine (3i)44 Yield: 0.112 g (88%), brown oil. 1H NMR (400 MHz, CDCl3): δ = 10.68 (br, 1 H), 8.08–8.06 (dd, J = 5.0 Hz, 1.6 Hz, 1 H), 7.77–7.75 (m, 2 H), 7.48–7.46 (dd, J = 7.7 Hz, 1.6 Hz, 1 H), 6.74–6.71 (q, J = 7.7 Hz, 5.0 Hz, 1 H), 6.48 (t, J = 2.1 Hz, 1 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 152.7, 146.6, 140.9, 143.3, 130.4, 129.6, 121.6, 113.2, 107.1 ppm. MS (ESI+): m/z = 161.03 [M + H]+. 2-(1H-Pyrazol-1-yl)benzonitrile (3j)45 Yield: 0.118 g (87%), yellow oil. 1H NMR (400 MHz, CDCl3): δ = 8.15 (d, J = 2.5 Hz, 1 H), 7.81–7.70 (m, 3 H), 7.73–7.69 (dt, J = 7.6 Hz, 1.5 Hz, 1 H), 7.45–7.41 (dt, J = 7.6 Hz, 1.0 Hz, 1 H), 6.55 (t, J = 2.1 Hz, 1 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 142.3, 142.1, 134.5, 134.0, 129.5, 127.2, 124.3, 117.0, 108.5, 105.4 ppm. MS (ESI+): m/z = 170.07 [M + H]+. 1-(4-Chlorophenyl)-1H-indole-2-carboxylic Acid (3k) Yield: 0.160 g (74%), white to pale grey solid; mp 227–230 °C. 1H NMR (400 MHz, CDCl3): δ = 7.75–7.73 (dt, J = 8.4 Hz, 0.9 Hz, 1 H), 7.57 (d, J = 0.7 Hz, 1 H), 7.50–7.47 (m, 2 H), 7.33–7.26 (m, 3 H), 7.23–7.19 (m, 1 H), 7.09–7.06 (m, 1 H) ppm. 13C NMR (150 MHz, DMSO-d 6): δ = 162.2, 140.4, 137.5, 132.7, 130.1, 129.4, 126.6, 125.9, 121.7, 111.6 ppm. MS (ESI–): m/z = 270.02 [M – H]–. 1-(Thiophen-2-yl)-1H-indole-2-carboxylic Acid (3l) Yield: 0.169 g (87%), white solid; mp 175–176 °C. 1H NMR (400 MHz, CDCl3): δ = 10.02 (s, 1 H), 8.55 (s, 1 H), 8.41–8.38 (m, 2 H), 8.23 (s, 1 H), 7.97–7.94 (m, 2 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 165.8, 142.4, 138.9, 128.9, 126.5, 126.0, 125.9,125.5, 125.0, 122.6, 121.9, 114.6, 111.8 ppm. MS (ESI–): m/z = 241.99 [M – H]–. 1-(Thiophen-3-yl)-1H-indole-2-carboxylic Acid (3m) Yield: 0.177 g (91%), white to a pale grey solid; mp 190–192 °C. 1H NMR (400 MHz, CDCl3): δ = 7.74–7.71 (dt, J = 7.9 Hz, 1.0 Hz, 1 H), 7.55 (d, J = 0.6 Hz, 1 H), 7.43–7.41 (m, 1 H), 7.34–7.30 (m, 2 H), 7.22–7.17 (m, 2 H), 7.09–7.07 (q, J = 5.2 Hz, 1.4 Hz, 1 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 165.8, 141.2, 135.8, 127.8, 126.8, 126.2, 125.9, 124.9, 122.6, 121.5, 121.2, 113.7, 111.7 ppm. MS (ESI–): m/z = 242.02 [M – H]–. 1-Phenyl-1H-indole-3-carbaldehyde (3n)46 Yield: 0.157 g (89%), brown oil. 1H NMR (400 MHz, CDCl3): δ = 10.12 (s, 1 H), 8.40–8.38 (m, 1 H), 7.92 (s, 1 H), 7.61–7.57 (m, 2 H), 7.54–7.47 (m, 4 H), 7.39–7.32 (m, 2 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 184.9, 138.2, 138.1, 137.5, 130.0, 128.3, 125.6, 124.9, 124.6, 123.5, 122.3, 119.7, 111.1 ppm. MS (ESI+): m/z = 222.07 [M + H]+. Phenyl-1H-pyrrolo[2,3-b]pyridine-3-carbaldehyde (3o) Yield: 0.124 g (70%), yellow solid; mp 238–240 °C. 1H NMR (400 MHz, CDCl3): δ = 10.10 (s, 1 H), 8.69–8.66 (dd, J = 7.8 Hz, 1.6 Hz, 1 H), 8.49-8.48 (dd, J = 4.8 Hz, 1.6 Hz, 1 H), 8.12 (s, 1 H), 7.76–7.74 (m, 2 H), 7.62–7.57 (m, 2 H), 7.49–7.45 (m, 1 H), 7.36–7.33 (q, J = 7.8 Hz, 4.8 Hz, 1 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 184.8, 148.5, 145.7, 137.5, 137.0, 130.8, 129.6, 128.0, 124.5, 119.5, 118.2, 117.6 ppm. MS (ESI+): m/z = 223.12 [M + H]+. 2-Chloro-4-(1H-pyrazol-1-yl)aniline (3p) Yield: 0.133 g (86%), light yellow solid; mp 70–73 °C. 1H NMR (400 MHz, CDCl3): δ = 7.77 (d, J = 2.4 Hz, 1 H), 7.70 (d, J = 1.5 Hz, 1 H), 7.61 (d, J = 2.5 Hz, 1 H), 7.39–7.36 (dd, J = 8.6 Hz, 2.5 Hz, 1 H), 6.81 (d, J = 8.6 Hz, 1 H), 6.42 (t, J = 2.1 Hz, 1 H), 4.09 (br, 2 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 144.5, 141.2, 131.4, 128.4, 120.7, 119.9, 118.2, 116.7, 108.3 ppm. MS (ESI+): m/z = 194.05 [M + H]+. 2-(1H-Pyrazol-1-yl)benzoic Acid (3q)47 Yield: 0.134 g (89%), white solid; mp 128–129 °C. 1H NMR (400 MHz, CDCl3): δ = 11.41 (br, 1 H), 8.06–8.04 (dd, J = 7.8 Hz, 1.1 Hz, 1 H), 7.77–7.75 (m, 2 H), 7.63–7.59 (m, 1 H), 7.50–7.46 (t, J = 7.5 Hz, 1 H), 7.43 (d, J = 7.8 Hz, 1 H), 6.49–6.48 (t, J = 2.1 Hz, 1 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 168.8, 141.0, 138.6, 132.7, 132.3, 131.0, 128.2, 127.1, 125.7, 107.6 ppm. MS (ESI–): m/z = 187.06 [M – H]–. 1-(4-Nitrophenyl)-1H-pyrazole (3r)36 Yield: 0.130 g (86%), yellow solid; mp 167–168 °C (lit. mp 168.5–169 °C). 1H NMR (400 MHz, CDCl3): δ = 8.37–8.33 (m, 2 H), 8.04 (d, J = 2.6 Hz, 1 H), 7.91–7.87 (m, 2 H), 7.81 (d, J = 1.5 Hz, 1 H), 6.57–5.56 (q, J = 2.4 Hz, 1.9 Hz, 1 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 140.8, 129.6, 125.6, 120.6, 119.3, 110.4 ppm. MS (ESI+): m/z = 190.08 [M + H]+. 3-Nitro-4-(1H-pyrazol-1-yl)aniline (3s) Yield: 0.156 g (96%), yellow solid; mp 135–136 °C. 1H NMR (400 MHz, CDCl3): δ = 7.69 (d, J = 1.0 Hz, 1 H), 7.60 (d, J = 2.4 Hz, 1 H), 7.31 (d, J = 8.6 Hz, 1 H), 7.13 (d, J = 2.6 Hz, 1 H), 6.88–6.85 (dd, J = 8.6 Hz, 2.6 Hz, 1 H), 6.44 (t, J = 2.0 Hz, 1 H), 3.85 (br, 2 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 147.0, 145.7, 141.3, 130.3, 128.4, 124.3, 118.1, 109.9, 107.1 ppm. MS (ESI+): m/z = 205.06 [M + H]+. 4-Chloro-2-(1H-pyrazol-1-yl)benzoic Acid (3t) Yield: 0.172 g (97%), pale grey solid; mp 237–240 °C. 1H NMR (400 MHz, DMSO-d 6): δ = 8.20 (d, J = 2.4 Hz, 1 H), 7.73–7.71 (m, 3 H), 7.57–7.54 (dd, J = 8.3 Hz, 2.0 Hz, 1 H), 6.51–6.50 (q, J = 2.4 Hz, 1.9 Hz, 1 H) ppm. 13C NMR (150 MHz, DMSO-d 6): δ = 168.5, 142.3, 140.4, 136.7, 132.5, 131.8, 128.5, 128.4, 125.4, 108.8 ppm. MS (ESI+): m/z = 220.94 [M + H]+, 222.93 [M + H]+. 1-(4-Nitrophenyl)-1H-indol-5-ol (3u) Yield: 0.216 g (85%), yellow solid; mp 188–191 °C. 1H NMR (400 MHz, CDCl3): δ = 8.40 (d, J = 9.0 Hz, 2 H), 7.67 (d, J = 9.0 Hz, 2 H), 7.53 (d, J = 8.8 Hz, 1 H), 7.36 (d, J = 3.3 Hz, 1 H), 7.09 (d, J = 2.4 Hz, 1 H), 6.87–6.84 (dd, J = 8.8 Hz, 2.4 Hz, 1 H), 6.66 (d, J = 3.2 Hz, 1 H), 4.60 (br, 1 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 152.8, 145.2, 144.2, 131.5, 129.2, 128.6, 125.9, 122.8, 113.2, 111.9, 105.8, 105.7 ppm. MS (ESI–): m/z = 253.06 [M – H]–. Ethyl 5-Hydroxy-2-methyl-1-phenyl-1H-indole-3-carboxylate (3v)48 Yield: 0.174 g (59%), brown solid; mp 203–205 °C (lit. mp 203–204 °C). 1H NMR (600 MHz, DMSO-d 6): δ = 9.06 (s, 3 H), 7.63 (t, J = 7.4 Hz, 2 H), 7.57 (t, J = 7.3 Hz, 1 H), 7.47 (d, J = 2.3 Hz, 1 H), 7.45 (d, J = 7.3 Hz, 2 H), 6.78 (d, J = 8.7 Hz, 1 H), 6.65–6.63 (dd, J = 8.8 Hz, 2.4 Hz, 1 H), 4.33–4.30 (q, J = 14.2 Hz, 7.1 Hz, 2 H), 2.49 (s, 3 H), 1.38 (t, J = 7.1 Hz, 3 H) ppm. 13C NMR (150 MHz, DMSO-d 6): δ = 165.6, 153.6, 145.3, 136.5, 131.9, 130.3, 129.3, 128.4, 127.5, 112.5, 111.2, 105.9, 104.0, 59.4, 15.0, 13.3 ppm. MS (ESI+): m/z = 296.12 [M + H]+. Ethyl 1-(4-Ethoxyphenyl)-5-hydroxy-2-methyl-1H-indole-3-carboxylate (3w) Yield: 0.210 g (62%), brown solid; mp 225–226 °C. 1H NMR (600 MHz, DMSO-d 6): δ = 9.02 (s, 1 H), 7.45 (d, J = 2.2 Hz, 1 H), 7.33 (d, J = 8.8 Hz, 2 H), 7.13 (d, J = 8.8 Hz, 2 H), 6.75 (d, J = 8.6 Hz, 1 H), 6.63–6.61 (dd, J = 8.7 Hz, 2.3 Hz, 1 H), 4.32–4.29 (q, J = 14.2 Hz, 7.1 Hz, 2 H), 4.13–4.10 (q, J = 13.7 Hz, 6.9 Hz, 2 H), 2.46 (s, 3 H), 1.39–1.36 (q, J = 14.1 Hz, 7.0 Hz, 6 H) ppm. 13C NMR (150 MHz, DMSO-d 6): δ = 165.6, 159.0, 153.5, 145.6, 132.3, 129.6, 128.8, 127.4, 115.8, 112.4, 111.2, 105.9, 103.6, 63.9, 59.3, 15.1, 15.0, 13.3 ppm. MS (ESI+): m/z = 340.16 [M + H]+. Ethyl 5-Hydroxy-2-methyl-1-(p-tolyl)-1H-indole-3-carboxylate (3x)49 Yield: 0.170 g (55%), yellow solid; mp 190–192 °C. 1H NMR (600 MHz, DMSO-d 6): δ = 9.03 (s, 1 H), 7.45–7.41 (m, 3 H), 7.31 (d, J = 7.5 Hz, 2 H), 6.77 (d, J = 8.5 Hz, 1 H), 6.63 (d, J = 8.1 Hz, 1 H), 4.32–4.29 (q, J = 14.0 Hz, 7.1 Hz, 2 H), 2.47 (s, 3 H), 2.43 (s, 3 H), 1.37 (t, J = 6.8 Hz, 3 H) ppm. 13C NMR (150 MHz, DMSO-d 6): δ = 165.6, 153.5, 145.4, 138.9, 133.9, 132.0, 130.8, 128.2, 127.5, 112.4, 111.2, 105.9, 103.8, 59.4, 21.2, 15.0, 13.3 ppm. MS (ESI+): m/z = 310.13 [M + H]+. Ethyl 5-Hydroxy-2-methyl-1-[3-(trifluoromethyl)phenyl]-1H-indole-3-carboxylate (3y) Yield: 0.229 g (63%), white solid; mp 199–201 °C. 1H NMR (600 MHz, DMSO-d 6): δ = 9.09 (s, 1 H), 7.96 (d, J = 7.8 Hz, 1 H), 7.92 (s, 1 H), 7.87 (t, J = 7.9 Hz, 1 H), 7.82 (d, J = 7.9 Hz, 1 H), 7.47 (d, J = 2.1 Hz, 1 H), 6.80 (d, J = 8.7 Hz, 1 H), 6.67–6.65 (dd, J = 8.7 Hz, 2.2 Hz, 1 H), 4.34–4.31 (q, J = 14.2 Hz, 7.1 Hz, 2 H), 1.38 (t, J = 7.1 Hz, 3 H) ppm. 13C NMR (150 MHz, DMSO-d 6): δ = 165.5, 153.7, 145.4, 137.3, 132.9, 131.7, 131.6, 131.1 (J = 31.9 Hz), 127.6, 126.1 (J = 3.5 Hz), 125.4 (J = 3.8 Hz), 125.0, 123.2, 112.7, 111.0, 106.0, 104.5, 59.5, 15.0, 13.3 ppm. MS (ESI+): m/z = 364.15 [M + H]+. 4-(1H-Pyrazol-1-yl)phenol (3z)50 Yield: 0.158 g (99%), white solid; mp 99–101 °C (lit. mp 94–96 °C) 1H NMR (400 MHz, CDCl3): δ = 7.77–7.72 (m, 2 H), 7.41–7.37 (m, 2 H), 6.82–6.78 (m, 2 H), 6.45 (t, J = 2.1 Hz, 1 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 155.6, 140.3, 132.9, 127.8, 121.9, 116.2, 107.1 ppm. MS (ESI+): m/z = 161.02 [M + H]+. N-[2-(1-phenyl-1H-indol-3-yl)ethyl]aniline (3aa) Yield: 0.271 g (87%), yellow solid; mp 85–87 °C. 1H NMR (400 MHz, CDCl3): δ = 7.67–7.65 (m, 1 H), 7.58–7.56 (m, 1 H), 7.53–7.46 (m, 1 H), 7.35–7.30 (m, 1 H), 7.26–7.16 (m, 5 H), 6.73–6.69 (m, 1 H), 6.66–6.63 (m, 2 H), 3.98 (br, 1 H), 3.53 (t, J = 6.9 Hz, 2 H), 3.16–3.12 (m, 2 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 148.0, 139.7, 136.1, 129.6, 128.8, 126.2, 125.7, 124.1, 122.6, 120.0, 119.1, 117.4, 114.4, 113.0, 110.6, 43.9, 25.0 ppm. MS (ESI+): m/z = 313.18 [M + H]+. 3-(1H-Pyrazol-1-yl)aniline (3ab)51 Yield: 0.141 g (89%), brown oil. 1H NMR (400 MHz, CDCl3): δ = 7.89 (d, J = 2.3 Hz, 1 H), 7.70 (d, J = 1.5 Hz, 1 H), 7.20 (t, J = 8.0 Hz, 1 H), 7.10 (t, J = 2.2 Hz, 1 H), 7.01–6.99 (m, 1 H), 6.61–6.58 (m, 1 H), 6.44 (t, J = 2.0 Hz, 1 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 147.6, 140.8, 130.2, 126.8, 113.1, 109.0, 107.3, 106.1 ppm. MS (ESI+): m/z = 160.07 [M + H]+. 5-Methoxy-2-phenylbenzo[d]oxazole (3ac)52 Yield: 0.129 g (72%), white solid; mp 66–69 °C (lit. mp 60–61 °C). 1H NMR (400 MHz, CDCl3): δ = 8.24–8.22 (m, 2 H), 7.52–7.51 (m, 3 H), 7.45 (d, J = 8.8 Hz, 1 H), 7.27 (d, J = 2.5 Hz, 1 H), 6.96–6.93 (dd, J = 2.6 Hz, 8.9 Hz, 1 H), 3.87 (s, 3 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 163.7, 157.3, 145.3, 142.8, 131.3, 128.8, 128.7, 127.4, 127.2, 113.7, 110.6, 102.8, 55.9 ppm. MS (ESI+): m/z = 226.10 [M + H]+. 3 -Nitro-5a,6,7,8,9,10-hexahydro-5H-benzo[4,5]imidazo[1,2-a]azepine (3ad) Yield: 0.160 g (86%), yellow solid; mp 171 °C (lit. mp 170–171 °C). 1H NMR (400 MHz, CDCl3): δ = 8.58 (d, J = 2.1 Hz, 1 H), 8.18 (dd, J = 9.0, 2.2 Hz, 1 H), 7.32 (d, J = 9.0 Hz, 1 H), 4.24–4.21 (m, 2 H), 3.17–3.14 (m, 2 H), 2.02–1.96 (m, 2 H), 1.92–1.82 (m, 4 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 161.2, 143.1, 141.6, 117.9, 115.8, 108.5, 45.1, 30.5, 30.1, 28.5, 25.1 ppm. MS (ESI+): m/z = 232.14 [M + H]+. 2-Methyl-1-phenyl-1H-benzo[d]imidazole (3ae)53 Yield: 0.116 g (70%), white solid; mp 62–65 °C (lit. mp 68 °C). 1H NMR (400 MHz, CDCl3): δ = 7.76 (d, J = 7.9 Hz, 1 H), 7.60–7.56 (m, 2 H), 7.54–7.49 (m, 1 H), 7.38–7.35 (m, 2 H), 7.29–7.24 (m, 1 H), 7.21–7.17 (m, 1 H), 7.14–7.12 (m, 1 H), 2.51 (s, 3 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 151.6, 142.7, 136.5, 136.1, 129.9, 128.8, 127.1, 122.6, 122.4, 119.0, 109.9, 14.5 ppm. MS (ESI+): m/z = 209.11 [M + H]+. 5-Nitro-2-(1H-pyrazol-1-yl)aniline (3af) Yield: 0.081 g (50%), red solid; mp 100 °C. 1H NMR (400 MHz, CDCl3): δ = 7.83–7.80 (m, 2 H), 7.69 (d, J = 2.4 Hz, 1 H), 7.63–7.60 (dd, J = 8.7 Hz, 2.5 Hz, 1 H), 7.33 (d, J = 8.7 Hz, 1 H), 6.52 (t, J = 2.3 Hz, 1 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 147.0, 141.3, 141.2, 129.9, 129.7, 123.1, 112.5, 111.9, 107.5 ppm. MS (ESI+): m/z = 205.10 [M + H]+. 2-Phenyl-5-(trifluoromethyl)benzo[d]oxazole (3ag)52 Yield: 0.185 g (88%), white solid; mp 83 °C (lit. mp 86–87 °C). 1H NMR (400 MHz, CDCl3): δ = 8.95 (d, J = 1.9 Hz, 1 H), 8.56 (br, 1 H), 7.96–7.93 (m, 2 H), 7.73–7.70 (m, 1 H), 7.64–7.60 (m, 1 H), 7.57–7.51 (m, 2 H), 7.29–7.26 (m, 1 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 136.4, 133.9, 132.6, 132.5, 131.0 (J = 33.0 Hz), 129.0, 128.8, 127.0, 123.5 (J = 271.0 Hz), 121.5 (J = 3.5 Hz), 118.3 (J = 3.7 Hz), 116.8 ppm. MS (ESI+): m/z = 264.05 [M + H]+. 5-(1H-Pyrazol-1-yl)-2-(trifluoromethyl)pyridine (3ah) Yield: 0.198 g (93%), white solid; mp 115–117 °C. 1H NMR (400 MHz, CDCl3): δ = 9.10 (d, J = 2.4 Hz, 1 H), 8.26–8.23 (dd, J = 8.5 Hz, 2.2 Hz, 1 H), 8.04 (d, J = 2.6 Hz, 1 H), 7.82 (d, J = 1.6 Hz, 1 H), 7.80 (d, J = 8.5 Hz, 1 H), 6.58–6.57 (q, J = 2.4 Hz, 1.8 Hz, 1 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 145.4 (J = 36.0 Hz), 142.8, 140.1, 138.2, 126.8, 126.7, 121.3 (J = 273.1 Hz), 121.2 (J = 2.3 Hz), 109.3 ppm. MS (ESI+): m/z = 214.08 [M + H]+. 1-[3-(Trifluoromethyl)phenyl]-1H-pyrazole (3ai)54 Yield: 0.201 g (95%), colorless oil. 1H NMR (400 MHz, CDCl3): δ = 8.00 (br, 1 H), 7.98 (d, J = 1.9 Hz, 1 H), 7.90–7.88 (dt, J = 7.8 Hz, 0.9 Hz, 1 H), 7.76 (d, J = 1.4 Hz, 1 H), 7.60–7.53 (m, 2 H), 6.51 (t, J = 1.9 Hz, 1 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 141.7, 140.4, 131.9 (J = 32.7 Hz), 130.0, 126.7, 123.6 (J = 271.2 Hz), 122.8 (J = 3.4 Hz), 121.9, 115.9 (J = 3.6 Hz), 108.3 ppm. MS (ESI+): m/z = 213.05 [M + H]+. 1-(3-Chlorophenyl)-1H-pyrazole (3aj)55 Yield: 0.171 g (96%), white solid; mp 27–29 °C. 1H NMR (400 MHz, CDCl3): δ = 7.93 (br, 1 H), 7.75 (t, J = 1.9 Hz, 1 H), 7.74 (br, 1 H), 7.60–7.57 (m, 1 H), 7.37 (t, J = 8.0 Hz, 1 H), 7.27–7.24 (m, 1 H), 6.49 (br, 1 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 141.4, 141.0, 135.2, 130.4, 126.7, 126.3, 119.3, 116.9, 108.1 ppm. MS (ESI+): m/z = 179.02 [M + H]+, 181.03 [M + H]+. 1-(3-Methoxyphenyl)-1H-pyrazole (3ak)36 Yield: 0.156 g (90%), colorless oil. 1H NMR (400 MHz, CDCl3): δ = 7.92–791 (dd, J = 2.4 Hz, 0.4 Hz, 1 H), 7.72 (d, J = 1.5 Hz, 1 H), 7.36–7.31 (m, 2 H), 7.24–7.21 (m, 1 H), 6.85–6.82 (m, 1 H), 6.46–6.45 (q, J = 2.4 Hz, 1.9 Hz, 1 H), 3.87 (s, 3 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 160.5, 141.3, 140.9, 130.1, 126.9, 112.3, 111.1, 107.5, 105.0, 55.4 ppm. MS (ESI+): m/z = 175.10 [M + H]+. 5-(1H-Pyrazol-1-yl)pyrimidine (3al)56 Yield: 0.140 g (96%), white solid; mp 88–90 °C. 1H NMR (400 MHz, CDCl3): δ = 9.16 (s, 1 H), 8.00 (d, J = 2.5 Hz, 1 H), 7.83 (d, J = 1.6 Hz, 1 H), 6.59 (t, J = 1.9 Hz, 1 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 156.1, 147.0, 142.8, 134.6, 126.6, 109.2 ppm. MS (ESI+): m/z = 147.05 [M + H]+. 2,5-Di(1H-pyrazol-1-yl)pyridine (3am)57 Yield: 0.202 g (96%), white solid; mp 160–161 °C (lit. mp 162 °C). 1H NMR (400 MHz, CDCl3): δ = 8.78 (d, J = 1.5 Hz, 1 H), 8.59 (d, J = 2.4 Hz, 1 H), 8.19–8.10 (m, 2 H), 7.96 (d, J = 2.4 Hz, 1 H), 7.79 (d, J = 1.6 Hz, 1 H), 7.77 (s, 1 H), 6.54 (t, J = 2.1 Hz, 1 H), 6.50 (t, J = 2.0 Hz, 1 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 149.6, 142.2, 141.8, 138.5, 134.8, 129.5, 127.1, 126.7, 112.8, 108.3, 108.0 ppm. MS (ESI+): m/z = 212.10 [M + H]+. 4-(1H-Pyrazol-1-yl)pyridine (3an)55 Yield: 0.143 g (99%), white solid; mp 72–74 °C. 1H NMR (400 MHz, CDCl3): δ = 8.71 (br, 2 H), 8.05 (d, J = 2.4 Hz, 1 H), 7.79 (d, J = 1.5 Hz, 1 H), 7.67 (d, J = 4.0 Hz, 2 H), 6.55–6.54 (q, J = 2.6 Hz, 1.8 Hz, 1 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 151.1, 145.9, 142.5, 126.5, 112.5, 109.0 ppm. MS (ESI+): m/z = 146.02 [M + H]+. 1-(2-(Allyloxy)phenyl)-1H-pyrazole (3ao)58 Yield: 0.160 g (84%), colorless oil. 1H NMR (400 MHz, CDCl3): δ = 8.09 (s, 1 H), 7.77–7.74 (dd, J = 7.9 Hz, 1.4 Hz, 1 H), 7.73 (s, 1 H), 7.30–7.25 (m, 1 H), 7.10–7.03 (m, 2 H), 6.44 (s, 1 H), 6.06–5.96 (m, 1 H), 5.39–5.33 (m, 1 H), 5.29–5.25 (m, 1 H), 4.61–4.59 (dt, J = 5.1 Hz, 1.5 Hz, 2 H) ppm. 13C NMR (150 MHz, CDCl3): δ = 148.6, 140.6, 140.2, 131.4, 128.8, 127.6, 125.0, 123.1, 116.4, 108.4, 106.5, 69.7 ppm. MS (ESI+): m/z = 201.12 [M + H]+. Supplementary Material Supplementary Material Supporting Information